FDA Guidance to Curb Tobacco Use Falls Short
Washington, D.C. – The U.S.
National Press Releases
Statement on Appointment of Dr. Ned Sharpless as Acting FDA Commissioner
Washington, D.C. – The White House has announced its intention to appoint Dr. Ned Sharpless, current director of the National Cancer Institute (NCI), as acting commissioner of the Food and Drug Administration (FDA). Dr.
Administration Budget Risks Reversing Progress Against Cancer
The administration released its FY20 budget today including a $4.7 billion cut for medical research at the National Institutes of Health (NIH) including a nearly $900 million cut for the National Cancer Institute (NCI).
New Legislation Halts Surprise Bills for People with Medicare Coverage
Washington, D.C. – March 6, 2019 – Bipartisan legislation introduced today in the U.S. Senate and House of Representatives would ensure that surprise out-of-pocket expenses are not a barrier to lifesaving colorectal cancer screenings for seniors on Medicare.
Federal Court Orders FDA to Issue Final Rule Requiring Graphic Cigarette Warnings by March 15, 2020
WASHINGTON, D.C. – In a major victory for the nation’s health and the fight against tobacco, a federal court on Tuesday ordered the U.S. Food and Drug Administration (FDA) to issue a final rule mandating graphic health warnings on cigarette packs and advertising by March 15, 2020.
Statement on FDA Commissioner Scott Gottlieb’s Resignation
Washington, D.C. – Following is a statement from Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN), responding to reports that Food and Drug Administration (FDA) Commissioner Scott Gottlieb is resigning:
Proposed Health Plan Rule Changes Could Increase Patient Costs
Today the American Cancer Society Cancer Action Network (ACS CAN) submitted comments to the Department of Health and Human Services (HHS) on the Notice of Benefit and Payment Parameters, which would set the rules for health care plans in 2020.
New research shows structural barriers are the biggest reason for low participation in clinical trials
A research team led by the Fred Hutchinson Cancer Research Center have determined the most significant barriers to clinical trial participation. The study published in Journal of the National Cancer Institute (JNCI) upends the notion that patient factors are the driving forces behind why most clinical trials don’t meet their enrollment targets.
Report Calls On US To Join Global Movement To Accelerate The Elimination of Cervical Cancer Worldwide
The American Cancer Society Cancer Action Network (ACS CAN) released a report today titled, “Saving Women’s Lives: Accelerating Action to Eliminate Cervical Cancer Globally.”
E-Cigarettes Lead to 36 Percent Spike in Overall Tobacco Use Among Youth
Overall tobacco use among middle and high school students is on the rise driven largely by the overwhelming increase in youth e-cigarette use, according to data released by the Centers for Disease Control and Prevention (CDC) today.